Merck (MRK) Gross Margin (2009 - 2026)
Merck (MRK) recorded Gross Margin of 73.54% in Q2 2026, down 3.96 percentage points from 77.50% a year earlier and down 0.71 percentage points from the prior quarter.
Powered by 
Analysis
Merck (MRK) Gross Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Merck's Gross Margin came in at 72.97% as of Jun 30, 2026, down 3.64 percentage points year-over-year; for FY2025, it came in at 74.80%, down 1.52 percentage points from FY2024.
- Annual Gross Margin has a five-year change of +7.60 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 76.32% in FY2024 (+3.15 pp), 73.17% in FY2023 (+2.54 pp), 70.63% in FY2022 (-1.39 pp) and 72.02% in FY2021 (+4.82 pp).
- Quarterly Gross Margin has ranged from 66.15% in Q4 2025 to 77.98% in Q1 2025 over the past five years.
- On a year-over-year basis, Gross Margin has declined for three consecutive quarters, with an average year-over-year change of -1.16 percentage points over the last eight quarters.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 17.28 percentage points in Q4 2021, against a drop of 9.35 percentage points in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 74.24% (Q1 2026), 66.15% (Q4 2025) and 77.69% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 72.78% |
| 10 | Vertex Pharmaceuticals | 135.25 Bn | 107.26 Bn | 2.84 Bn | 85.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.54% |
| Mar 31, 2026 | 74.24% |
| Dec 31, 2025 | 66.15% |
| Sep 30, 2025 | 77.69% |
| Jun 30, 2025 | 77.50% |
| Mar 31, 2025 | 77.98% |
| Dec 31, 2024 | 75.50% |
| Sep 30, 2024 | 75.51% |
| Jun 30, 2024 | 76.76% |
| Mar 31, 2024 | 77.56% |
| Dec 31, 2023 | 73.26% |
| Sep 30, 2023 | 73.29% |
| Jun 30, 2023 | 73.24% |
| Mar 31, 2023 | 72.90% |
| Dec 31, 2022 | 71.94% |
| Sep 30, 2022 | 73.70% |
| Jun 30, 2022 | 71.11% |
| Mar 31, 2022 | 66.17% |
| Dec 31, 2021 | 71.35% |
| Sep 30, 2021 | 73.77% |
API Access
Merck Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();